Global Electrocompetent Cells Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Electrocompetent Cells Market Insights, Forecast to 2034
Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
Market Analysis and InsightsGlobal Electrocompetent Cells Market
Global Electrocompetent Cells market is expected to reach to US$ 774.7 million in 2023, with a positive growth of %, compared with US$ 713.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Electrocompetent Cells industry is evaluated to reach US$ 1335.4 million in 2033. The CAGR will be 9.5% during 2023 to 2033.
Globally, Electrocompetent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Electrocompetent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Electrocompetent Cells market and estimated to attract more attentions from industry insiders and investors.
Electrocompetent Cells can be divided into Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells and Expression Competent Cells,, etc. Cloned Competent Cells is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Electrocompetent Cells is widely used in various fields, such as Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning and High-Throughput Cloning, etc. Subcloning & Routine Cloning provides greatest supports to the Electrocompetent Cells industry development. In 2022, global % revenue of Electrocompetent Cells went into Subcloning & Routine Cloning filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Electrocompetent Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Electrocompetent Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Electrocompetent Cells introduction, etc. Electrocompetent Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Electrocompetent Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Electrocompetent Cells Market
Global Electrocompetent Cells market is expected to reach to US$ 774.7 million in 2023, with a positive growth of %, compared with US$ 713.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Electrocompetent Cells industry is evaluated to reach US$ 1335.4 million in 2033. The CAGR will be 9.5% during 2023 to 2033.
Globally, Electrocompetent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Electrocompetent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Electrocompetent Cells market and estimated to attract more attentions from industry insiders and investors.
Electrocompetent Cells can be divided into Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells and Expression Competent Cells,, etc. Cloned Competent Cells is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Electrocompetent Cells is widely used in various fields, such as Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning and High-Throughput Cloning, etc. Subcloning & Routine Cloning provides greatest supports to the Electrocompetent Cells industry development. In 2022, global % revenue of Electrocompetent Cells went into Subcloning & Routine Cloning filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Electrocompetent Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Electrocompetent Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Electrocompetent Cells introduction, etc. Electrocompetent Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Electrocompetent Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch